RK PHARMA INC.
8Patents
8Active
8Granted
46Portfolio score
Filing activity: Jun 11, 2020 → Jun 2, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11447513B2 | Purification process of ferric carboxymaltose | Chemistry; Metallurgy | 0 | Active |
| US11857677B2 | Ready to use injectable formulations of melphalan and processes for preparation thereof | Human Necessities | 0 | Active |
| US12257219B2 | Storage stable aqueous parenteral solutions comprising diclofenac | Human Necessities | 0 | Active |
| US12396999B2 | Composition of ferric maltol for oral administration | Human Necessities | 0 | Active |
| US11654151B2 | Storage-stable ready-to-use formulations of tigecycline | Human Necessities | 0 | Active |
| US11447499B2 | Process for the preparation of eribulin mesylate intermediate | Chemistry; Metallurgy | 0 | Active |
| US11707443B2 | Storage stable aqueous parenteral solutions comprising diclofenac | Human Necessities | 0 | Active |
| US11850224B2 | Storage stable aqueous injectable solution comprising diclofenac | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.